176 related articles for article (PubMed ID: 35008480)
1. MicroRNA 630 Represses NANOG Expression through Transcriptional and Post-Transcriptional Regulation in Human Embryonal Carcinoma Cells.
Chu WK; Hung LM; Hou CW; Chen JK
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008480
[TBL] [Abstract][Full Text] [Related]
2. The miR-134 attenuates the expression of transcription factor FOXM1 during pluripotent NT2/D1 embryonal carcinoma cell differentiation.
Chen Y; Meng L; Yu Q; Dong D; Tan G; Huang X; Tan Y
Exp Cell Res; 2015 Jan; 330(2):442-450. PubMed ID: 25447206
[TBL] [Abstract][Full Text] [Related]
3. Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells.
Kalmar T; Lim C; Hayward P; Muñoz-Descalzo S; Nichols J; Garcia-Ojalvo J; Martinez Arias A
PLoS Biol; 2009 Jul; 7(7):e1000149. PubMed ID: 19582141
[TBL] [Abstract][Full Text] [Related]
4. Protein arginine methyltransferase 7-mediated
Chen TY; Lee SH; Dhar SS; Lee MG
J Biol Chem; 2018 Mar; 293(11):3925-3936. PubMed ID: 29378844
[TBL] [Abstract][Full Text] [Related]
5. Nanog expression is negatively regulated by protein kinase C activities in human cancer cell lines.
Chu WK; Dai PM; Li HL; Pao CC; Chen JK
Carcinogenesis; 2013 Jul; 34(7):1497-509. PubMed ID: 23536578
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-15a, microRNA-15b and microRNA-16 inhibit the human dopamine D1 receptor expression in four cell lines by targeting 3'UTR -12 bp to + 154 bp.
Wu X; Xu FL; Xia X; Wang BJ; Yao J
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):276-287. PubMed ID: 31858826
[No Abstract] [Full Text] [Related]
7. Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells.
Choi SC; Choi JH; Park CY; Ahn CM; Hong SJ; Lim DS
J Cell Physiol; 2012 Nov; 227(11):3678-92. PubMed ID: 22378194
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA
Xie D; Tong M; Xia B; Feng G; Wang L; Li A; Luo G; Wan H; Zhang Z; Zhang H; Yang YG; Zhou Q; Wang M; Wang XJ
RNA Biol; 2021 Jun; 18(6):875-887. PubMed ID: 32991228
[TBL] [Abstract][Full Text] [Related]
9. Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression.
You JS; Kang JK; Seo DW; Park JH; Park JW; Lee JC; Jeon YJ; Cho EJ; Han JW
Cancer Res; 2009 Jul; 69(14):5716-25. PubMed ID: 19567677
[TBL] [Abstract][Full Text] [Related]
10. Epithelium-specific ETS transcription factor-1 regulates NANOG expression and inhibits NANOG-induced proliferation of human embryonic carcinoma cells.
Park SW; Do HJ; Choi W; Lim DS; Park KH; Kim JH
Biochimie; 2021 Jul; 186():33-42. PubMed ID: 33865902
[TBL] [Abstract][Full Text] [Related]
11. The HIV-1 capsid-binding host factor CPSF6 is post-transcriptionally regulated by the cellular microRNA miR-125b.
Chaudhuri E; Dash S; Balasubramaniam M; Padron A; Holland J; Sowd GA; Villalta F; Engelman AN; Pandhare J; Dash C
J Biol Chem; 2020 Apr; 295(15):5081-5094. PubMed ID: 32152226
[TBL] [Abstract][Full Text] [Related]
12. PKC Regulates YAP Expression through Alternative Splicing of YAP 3'UTR Pre-mRNA by hnRNP F.
Chu WK; Hung LM; Hou CW; Chen JK
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445676
[TBL] [Abstract][Full Text] [Related]
13. Comparative SRY incorporation on the regulatory regions of pluripotency/differentiation genes in human embryonic carcinoma cells after retinoic acid induction.
Kakhki SA; Shahhoseini M; Salekdeh GH
Mol Cell Biochem; 2013 Apr; 376(1-2):145-50. PubMed ID: 23361361
[TBL] [Abstract][Full Text] [Related]
14. Regulation of human growth and differentiation factor 3 gene expression by NANOG in human embryonic carcinoma NCCIT cells.
Park SW; Lim HY; Do HJ; Sung B; Huh SH; Uhm SJ; Song H; Chung HJ; Kim JH; Kim NH; Kim JH
FEBS Lett; 2012 Sep; 586(19):3529-35. PubMed ID: 22963770
[TBL] [Abstract][Full Text] [Related]
15. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells.
Sheik Mohamed J; Gaughwin PM; Lim B; Robson P; Lipovich L
RNA; 2010 Feb; 16(2):324-37. PubMed ID: 20026622
[TBL] [Abstract][Full Text] [Related]
16. 3'UTR mediated regulation of the cyclin D1 proto-oncogene.
Deshpande A; Pastore A; Deshpande AJ; Zimmermann Y; Hutter G; Weinkauf M; Buske C; Hiddemann W; Dreyling M
Cell Cycle; 2009 Nov; 8(21):3592-600. PubMed ID: 19823025
[TBL] [Abstract][Full Text] [Related]
17. A feedback loop comprising PRMT7 and miR-24-2 interplays with Oct4, Nanog, Klf4 and c-Myc to regulate stemness.
Lee SH; Chen TY; Dhar SS; Gu B; Chen K; Kim YZ; Li W; Lee MG
Nucleic Acids Res; 2016 Dec; 44(22):10603-10618. PubMed ID: 27625395
[TBL] [Abstract][Full Text] [Related]
18. Regulation of UDP-Glucuronosyltransferase 2B15 by miR-331-5p in Prostate Cancer Cells Involves Canonical and Noncanonical Target Sites.
Wijayakumara DD; Mackenzie PI; McKinnon RA; Hu DG; Meech R
J Pharmacol Exp Ther; 2018 Apr; 365(1):48-59. PubMed ID: 29367276
[No Abstract] [Full Text] [Related]
19. The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells.
Shi G; Gao F; Jin Y
J Cell Physiol; 2011 Dec; 226(12):3190-6. PubMed ID: 21321941
[TBL] [Abstract][Full Text] [Related]
20. The role of the 3'UTR region in the regulation of the ACVR1/Alk-2 gene expression.
Mura M; Cappato S; Giacopelli F; Ravazzolo R; Bocciardi R
PLoS One; 2012; 7(12):e50958. PubMed ID: 23227223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
